tiprankstipranks
Annexon Biosciences (ANNX)
NASDAQ:ANNX
US Market

Annexon Biosciences (ANNX) Income Statement

Compare
860 Followers

Annexon Biosciences Income Statement

Last quarter (Q3 2024), Annexon Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Annexon Biosciences's net income was $-34.82M. See Annexon Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -3.27M$ -3.31M$ -3.41M$ -667.00K$ -493.00K
Operating Expenses
$ 143.72M$ 145.60M$ 130.71M$ 63.47M$ 32.52M
Depreciation and Amortization
$ 2.15M$ 3.31M$ 3.41M$ 667.00K$ 493.00K
EBITDA
$ -141.57M$ -143.49M$ -128.57M$ -62.80M$ -32.02M
Operating Income
$ -143.72M$ -145.60M$ -130.71M$ -63.47M$ -32.52M
Other Income/Expenses
$ 9.49M$ 3.65M$ 390.00K$ 57.00K$ -4.66M
Pretax Income
$ -134.24M$ -141.95M$ -130.32M$ -63.41M$ -37.18M
Net Income
$ -134.24M$ -138.29M$ -127.79M$ -62.74M$ -37.18M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.77$ -2.53$ -3.34$ -3.70$ -0.97
Diluted EPS
$ -1.77$ -2.53$ -3.34$ -3.70$ -0.97
Weighted Average Shares Outstanding
75.67M 54.67M 38.32M 16.96M 38.22M
Weighted Average Shares Outstanding (Diluted)
75.67M 54.67M 38.32M 16.96M 38.22M
Currency in USD

Annexon Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis